Health Pyxis Oncology Reports Inducement Grants Under Nasdaq Globe News Wire Dec 24, 2022 CAMBRIDGE, Mass., Dec. 23, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, reported on December 23, 2022…